amgen limited
amgen limited Company Information
Company Number
02354269
Website
www.amgen.co.ukRegistered Address
216 cambridge science park, milton road, cambridge, cambridgeshire, CB4 0WA
Industry
Research and experimental development on biotechnology
Telephone
01223420305
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
amgen worldwide holdings bv 100%
amgen limited Estimated Valuation
Pomanda estimates the enterprise value of AMGEN LIMITED at £711.3m based on a Turnover of £305.2m and 2.33x industry multiple (adjusted for size and gross margin).
amgen limited Estimated Valuation
Pomanda estimates the enterprise value of AMGEN LIMITED at £163.9m based on an EBITDA of £16.6m and a 9.85x industry multiple (adjusted for size and gross margin).
amgen limited Estimated Valuation
Pomanda estimates the enterprise value of AMGEN LIMITED at £180.9m based on Net Assets of £84.1m and 2.15x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Amgen Limited Overview
Amgen Limited is a live company located in cambridge, CB4 0WA with a Companies House number of 02354269. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in March 1989, it's largest shareholder is amgen worldwide holdings bv with a 100% stake. Amgen Limited is a mature, mega sized company, Pomanda has estimated its turnover at £305.2m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Amgen Limited Health Check
Pomanda's financial health check has awarded Amgen Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
6 Weak
Size
annual sales of £305.2m, make it larger than the average company (£3.5m)
£305.2m - Amgen Limited
£3.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (14.1%)
1% - Amgen Limited
14.1% - Industry AVG
Production
with a gross margin of 47.6%, this company has a comparable cost of product (53%)
47.6% - Amgen Limited
53% - Industry AVG
Profitability
an operating margin of 5.1% make it more profitable than the average company (-0.4%)
5.1% - Amgen Limited
-0.4% - Industry AVG
Employees
with 558 employees, this is above the industry average (44)
558 - Amgen Limited
44 - Industry AVG
Pay Structure
on an average salary of £126.5k, the company has a higher pay structure (£77.9k)
£126.5k - Amgen Limited
£77.9k - Industry AVG
Efficiency
resulting in sales per employee of £547k, this is more efficient (£136.2k)
£547k - Amgen Limited
£136.2k - Industry AVG
Debtor Days
it gets paid by customers after 127 days, this is later than average (51 days)
127 days - Amgen Limited
51 days - Industry AVG
Creditor Days
its suppliers are paid after 10 days, this is quicker than average (70 days)
10 days - Amgen Limited
70 days - Industry AVG
Stock Days
it holds stock equivalent to 84 days, this is more than average (48 days)
84 days - Amgen Limited
48 days - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Amgen Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 72%, this is a higher level of debt than the average (50%)
72% - Amgen Limited
50% - Industry AVG
AMGEN LIMITED financials
Amgen Limited's latest turnover from December 2022 is £305.2 million and the company has net assets of £84.1 million. According to their latest financial statements, Amgen Limited has 558 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 305,203,000 | 294,166,000 | 303,806,000 | 294,986,000 | 224,612,000 | 238,931,000 | 172,717,000 | 218,735,000 | 212,295,000 | 191,754,000 | 163,413,000 | 134,880,000 | 163,293,000 | 167,984,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Cost Of Sales | 159,876,000 | 150,753,000 | 147,049,000 | 138,641,000 | 98,946,000 | 87,487,000 | 0 | 124,009,000 | 127,060,000 | |||||
| Gross Profit | 145,327,000 | 143,413,000 | 156,757,000 | 156,345,000 | 125,666,000 | 151,444,000 | 172,717,000 | 39,284,000 | 40,924,000 | |||||
| Admin Expenses | 129,761,000 | 125,582,000 | 142,338,000 | 140,743,000 | 115,580,000 | 141,666,000 | 157,510,000 | 31,943,000 | 31,538,000 | |||||
| Operating Profit | 15,566,000 | 17,831,000 | 14,419,000 | 15,602,000 | 10,086,000 | 9,778,000 | 15,207,000 | 37,107,000 | 18,526,000 | 11,968,000 | 10,517,000 | 10,784,000 | 7,341,000 | 9,386,000 |
| Interest Payable | 1,423,000 | 3,291,000 | 716,000 | 287,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 1,195,000 | 451,000 | 109,000 | 126,000 | 113,000 | 18,000 | 135,000 | 203,000 | 118,000 | 328,000 | 185,000 | 66,000 | 111,000 | 46,000 |
| Pre-Tax Profit | 15,338,000 | 14,991,000 | 13,812,000 | 15,441,000 | 10,199,000 | 9,796,000 | 15,342,000 | 37,310,000 | 18,644,000 | 12,296,000 | 10,702,000 | 10,850,000 | 7,452,000 | 9,432,000 |
| Tax | -3,285,000 | -3,858,000 | -2,985,000 | -3,465,000 | -2,976,000 | -308,000 | -4,751,000 | -7,986,000 | -2,294,000 | 1,792,000 | -1,115,000 | 652,000 | -13,000 | -6,000 |
| Profit After Tax | 12,053,000 | 11,133,000 | 10,827,000 | 11,976,000 | 7,223,000 | 9,488,000 | 10,591,000 | 29,324,000 | 16,350,000 | 14,088,000 | 9,587,000 | 11,502,000 | 7,439,000 | 9,426,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 15,000,000 | 35,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 12,053,000 | 11,133,000 | 10,827,000 | 11,976,000 | 7,223,000 | -5,512,000 | -24,409,000 | 29,324,000 | 16,350,000 | 14,088,000 | 9,587,000 | 11,502,000 | 7,439,000 | 9,426,000 |
| Employee Costs | 70,594,000 | 63,528,000 | 65,817,000 | 60,033,000 | 56,463,000 | 51,391,000 | 52,265,000 | 48,825,000 | 59,278,000 | 52,980,000 | 50,370,000 | 54,657,000 | 50,120,000 | 44,658,000 |
| Number Of Employees | 558 | 540 | 567 | 518 | 504 | 504 | 481 | 482 | 528 | 526 | 501 | 532 | 529 | 489 |
| EBITDA* | 16,641,000 | 19,302,000 | 18,728,000 | 20,761,000 | 11,232,000 | 10,473,000 | 16,319,000 | 38,575,000 | 19,788,000 | 13,188,000 | 11,829,000 | 12,562,000 | 9,454,000 | 12,022,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 16,678,000 | 18,273,000 | 16,808,000 | 8,486,000 | 2,259,000 | 3,156,000 | 3,412,000 | 2,502,000 | 2,795,000 | 3,615,000 | 4,527,000 | 5,314,000 | 6,637,000 | 7,023,000 |
| Intangible Assets | 0 | 0 | 1,000 | 2,000 | 3,000 | 4,000 | 4,000 | 23,000 | 42,000 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 1,309,000 | 975,000 | 0 | 0 | 0 | 0 | 0 | 0 | 974,000 | 1,082,000 | 0 | 0 |
| Total Fixed Assets | 16,678,000 | 18,273,000 | 18,118,000 | 9,463,000 | 2,262,000 | 3,160,000 | 3,416,000 | 2,525,000 | 2,837,000 | 3,615,000 | 5,501,000 | 6,396,000 | 6,637,000 | 7,023,000 |
| Stock & work in progress | 36,835,000 | 36,123,000 | 56,354,000 | 52,284,000 | 17,733,000 | 16,849,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 106,930,000 | 94,001,000 | 79,434,000 | 69,210,000 | 25,180,000 | 22,385,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 124,302,000 | 110,056,000 | 61,085,000 | 52,023,000 | 44,884,000 | 50,896,000 | 47,475,000 | 102,408,000 | 111,257,000 | 89,199,000 | 71,938,000 | 52,169,000 | 39,340,000 | 74,139,000 |
| Misc Debtors | 15,094,000 | 16,018,000 | 25,030,000 | 19,593,000 | 24,416,000 | 18,982,000 | 17,508,000 | 13,110,000 | 14,728,000 | 17,544,000 | 14,580,000 | 11,616,000 | 6,951,000 | 7,186,000 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 601,000 | 494,000 | 729,000 | 3,070,000 | 3,704,000 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 283,161,000 | 256,198,000 | 221,903,000 | 193,110,000 | 112,814,000 | 109,606,000 | 65,712,000 | 118,588,000 | 129,689,000 | 106,743,000 | 86,518,000 | 63,785,000 | 46,291,000 | 81,325,000 |
| total assets | 299,839,000 | 274,471,000 | 240,021,000 | 202,573,000 | 115,076,000 | 112,766,000 | 69,128,000 | 121,113,000 | 132,526,000 | 110,358,000 | 92,019,000 | 70,181,000 | 52,928,000 | 88,348,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 4,524,000 | 3,966,000 | 4,582,000 | 4,468,000 | 3,491,000 | 7,461,000 | 7,480,000 | 5,068,000 | 1,919,000 | 1,023,000 | 1,182,000 | 1,241,000 | 1,605,000 | 1,548,000 |
| Group/Directors Accounts | 91,802,000 | 90,790,000 | 83,033,000 | 82,719,000 | 39,647,000 | 33,467,000 | 609,000 | 3,089,000 | 2,956,000 | 8,327,000 | 2,319,000 | 3,119,000 | 2,781,000 | 3,648,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 1,313,000 | 1,310,000 | 3,551,000 | 4,160,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 109,555,000 | 102,813,000 | 88,148,000 | 73,792,000 | 53,918,000 | 66,019,000 | 54,540,000 | 60,011,000 | 63,530,000 | 57,205,000 | 47,332,000 | 38,725,000 | 26,957,000 | 35,719,000 |
| total current liabilities | 207,194,000 | 198,879,000 | 179,314,000 | 165,139,000 | 97,056,000 | 106,947,000 | 62,629,000 | 68,168,000 | 68,405,000 | 66,555,000 | 50,833,000 | 43,085,000 | 31,343,000 | 40,915,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 7,824,000 | 9,112,000 | 9,594,000 | 3,181,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 1,280,000 | 1,158,000 | 1,520,000 | 636,000 | 3,042,000 | 3,705,000 | 4,051,000 | 3,579,000 |
| other liabilities | 0 | 0 | 0 | 0 | 599,000 | 939,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 713,000 | 842,000 | 2,371,000 | 1,840,000 | 2,092,000 | 2,092,000 | 2,092,000 | 4,917,000 | 1,358,000 | 1,358,000 | 1,358,000 | 0 | 0 | 0 |
| total long term liabilities | 8,537,000 | 9,954,000 | 11,965,000 | 5,021,000 | 2,691,000 | 3,031,000 | 3,372,000 | 6,075,000 | 2,878,000 | 1,994,000 | 4,400,000 | 3,705,000 | 4,051,000 | 3,579,000 |
| total liabilities | 215,731,000 | 208,833,000 | 191,279,000 | 170,160,000 | 99,747,000 | 109,978,000 | 66,001,000 | 74,243,000 | 71,283,000 | 68,549,000 | 55,233,000 | 46,790,000 | 35,394,000 | 44,494,000 |
| net assets | 84,108,000 | 65,638,000 | 48,742,000 | 32,413,000 | 15,329,000 | 2,788,000 | 3,127,000 | 46,870,000 | 61,243,000 | 41,809,000 | 36,786,000 | 23,391,000 | 17,534,000 | 43,854,000 |
| total shareholders funds | 84,108,000 | 65,638,000 | 48,742,000 | 32,413,000 | 15,329,000 | 2,788,000 | 3,127,000 | 46,870,000 | 61,243,000 | 41,809,000 | 36,786,000 | 23,391,000 | 17,534,000 | 43,854,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 15,566,000 | 17,831,000 | 14,419,000 | 15,602,000 | 10,086,000 | 9,778,000 | 15,207,000 | 37,107,000 | 18,526,000 | 11,968,000 | 10,517,000 | 10,784,000 | 7,341,000 | 9,386,000 |
| Depreciation | 1,075,000 | 1,471,000 | 4,308,000 | 5,159,000 | 1,145,000 | 690,000 | 1,112,000 | 1,468,000 | 1,262,000 | 1,220,000 | 1,312,000 | 1,778,000 | 2,113,000 | 2,636,000 |
| Amortisation | 0 | 0 | 1,000 | 0 | 1,000 | 5,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -3,285,000 | -3,858,000 | -2,985,000 | -3,465,000 | -2,976,000 | -308,000 | -4,751,000 | -7,986,000 | -2,294,000 | 1,792,000 | -1,115,000 | 652,000 | -13,000 | -6,000 |
| Stock | 712,000 | -20,231,000 | 4,070,000 | 34,551,000 | 884,000 | 16,849,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 26,251,000 | 53,217,000 | 25,057,000 | 47,321,000 | 2,217,000 | 27,280,000 | -50,535,000 | -10,467,000 | 19,242,000 | 19,251,000 | 22,625,000 | 18,576,000 | -35,034,000 | 81,325,000 |
| Creditors | 558,000 | -616,000 | 114,000 | 977,000 | -3,970,000 | -19,000 | 2,412,000 | 3,149,000 | 896,000 | -159,000 | -59,000 | -364,000 | 57,000 | 1,548,000 |
| Accruals and Deferred Income | 6,742,000 | 14,665,000 | 14,356,000 | 19,874,000 | -12,101,000 | 10,199,000 | -5,349,000 | -3,881,000 | 7,209,000 | 7,467,000 | 7,944,000 | 11,422,000 | -8,290,000 | 39,298,000 |
| Deferred Taxes & Provisions | -129,000 | -1,529,000 | 531,000 | -252,000 | 0 | 0 | -2,825,000 | 3,559,000 | 0 | 0 | 1,358,000 | 0 | 0 | 0 |
| Cash flow from operations | -6,436,000 | -5,022,000 | 1,617,000 | -43,977,000 | -10,916,000 | -23,784,000 | 56,341,000 | 43,883,000 | 6,357,000 | 3,037,000 | -2,668,000 | 5,696,000 | 36,242,000 | -28,463,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 1,012,000 | 7,757,000 | 314,000 | 43,072,000 | 6,180,000 | 32,858,000 | -2,480,000 | 133,000 | -5,371,000 | 6,008,000 | -800,000 | 338,000 | -867,000 | 3,648,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | -1,285,000 | -2,723,000 | 5,804,000 | 7,341,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | -599,000 | -340,000 | 939,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -228,000 | -2,840,000 | -607,000 | -161,000 | 113,000 | 18,000 | 135,000 | 203,000 | 118,000 | 328,000 | 185,000 | 66,000 | 111,000 | 46,000 |
| cash flow from financing | 5,916,000 | 7,957,000 | 11,013,000 | 54,761,000 | 11,271,000 | 38,988,000 | -21,679,000 | -43,361,000 | -2,169,000 | -2,729,000 | 3,193,000 | -5,241,000 | -34,515,000 | 38,122,000 |
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
amgen limited Credit Report and Business Information
Amgen Limited Competitor Analysis
Perform a competitor analysis for amgen limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
amgen limited Ownership
AMGEN LIMITED group structure
Amgen Limited has no subsidiary companies.
Ultimate parent company
AMGEN INC
#0017804
AMGEN WORLDWIDE HOLDINGS BV
#0017803
2 parents
AMGEN LIMITED
02354269
amgen limited directors
Amgen Limited currently has 3 directors. The longest serving directors include Mr Christopher Walker (Mar 2016) and Mr Russell Abberley (Aug 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Christopher Walker | United Kingdom | 53 years | Mar 2016 | - | Director |
| Mr Russell Abberley | England | 49 years | Aug 2020 | - | Director |
| Mr Paraskevi Florou | England | 44 years | Feb 2023 | - | Director |
P&L
December 2022turnover
305.2m
+4%
operating profit
15.6m
-13%
gross margin
47.7%
-2.33%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
84.1m
+0.28%
total assets
299.8m
+0.09%
cash
0
0%
net assets
Total assets minus all liabilities
amgen limited company details
company number
02354269
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
March 1989
age
35
accounts
Full Accounts
ultimate parent company
previous names
amgen (u.k.) limited (May 1989)
law 102 limited (April 1989)
incorporated
UK
address
216 cambridge science park, milton road, cambridge, cambridgeshire, CB4 0WA
last accounts submitted
December 2022
amgen limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to amgen limited.
amgen limited Companies House Filings - See Documents
| date | description | view/download |
|---|
